Investment Details

As of Oct 22, 2023

Sold out

Projected Return

2.2–5x*

(*MOIC)

Minimum Investment

USD 25'000

Investment Horizon

5-10 years

Currency

USD

Instrument

Structured Product, SSPA Tracker-Certificate (Code 1300)

Issuer

MISP AG, Zug, Switzerland

Issuer UID

CHE-392.560.573

CH-ID

CH-170-3046582-2

Setup Fee

1.25%

Admin Fee

2% p.a.

Performance Fee

20%

Lockup Period

5 years, or 6 months after IPO

Historical performance and/or return estimations/predictions do not guarantee current and future performance. The value of the investment may rise or fall at any time up to the complete loss of the invested capital. Please review the risk section in this product's official term sheet before investing.

Performance Simulator

Simulated Growth

CHF 100,000
CHF 25,000CHF 50,000CHF 75,000CHF 100,000CHF 150,000CHF 200,000CHF 250,000CHF 300,000CHF 400,000CHF 500,000CHF 1,000,000CHF 2,000,000CHF 5,000,000

Simulated Return

The business model

“In the long term, it is possible to restore full body motion.” - Elon Musk

Neuralink's business model centers on developing brain-computer interface (BCI) technology to connect human brains with computers. It aims to create medical and consumer applications, enabling communication and control through brain signals.


Neurological Disorders

Neuralink focuses on addressing neurological conditions through precise control and monitoring using advanced brain-computer interface (BCI) technology.


Enhanced Brain Function

Neuralink's goal is to enhance cognitive abilities, memory, and learning, ultimately unlocking human potential and improving mental well-being.


Human-Machine Integration

Neuralink aims to facilitate seamless interaction between humans and machines, revolutionizing control, communication, and interfacing with the digital world.

Neuralink chip design

Why we're investing

We estimate a 2.2-5x multiple within 5-10 years. Elon Musk's success stories have proven time and again that there is enormous demand for his companies. Large institutional investors, as well as private investors, have built significant trust in Elon Musk, and we believe this investment is virtually a no-brainer.

1
Revolutionizing healthcare

Neuralink's cutting-edge brain-computer interface technology has the potential to revolutionize healthcare by providing innovative solutions for neurological disorders and injuries. Investors can be part of a groundbreaking sector with the potential to save and enhance countless lives.

2
Massive market potential

The global neural interface market is projected to reach USD 30 billion by 2030, experiencing rapid expansion, with applications spanning from medical treatments to consumer tech. Neuralink provides a compelling entry point to this burgeoning sector.

3
Strong leadership and partnerships

Neuralink is led by Elon Musk, a visionary entrepreneur known for his success in multiple industries. The company also boasts partnerships with leading neuroscientists and engineers. This combination of leadership and expertise ensures that Neuralink has the resources and knowledge to tackle complex challenges.

4
Securing a competitive edge

Neuralink is at the forefront of human-machine integration, offering investors a competitive
advantage as the field evolves and expands. This technology may not only create new market opportunities but also become increasingly relevant across industries.

5
Potential for future monetization

Beyond healthcare, Neuralink's technology has broad applications in fields like augmented reality and virtual reality. This investment offers potential access to various revenue streams, making it a forward-thinking, long-term choice.

Impressive co-investors

Neuralink's investor lineup is impressive due to the blend of established venture capital firms, major corporations like Google, and forward-looking financial institutions, reflecting strong industry confidence in its potential.

“We have received FDA breakthrough device designation.” - Elon Musk.

One of the key hurdles for Neuralink had been to get approval from the US Food and Drug Association (FDA). This was a problem last year. Musk, in his presentation, announced that Neuralink has received FDA breakthrough designation and they are working towards significantly exceeding the minimum FDA guidelines for safety.

Watch video

Milestones

2016

Neuralink was founded

2017

First animal testing initiated

2019

Pig named Gertrude demonstrated implant

2020

Progress in brain-computer interfaces

2021

Human trials began, monkey success

2022

Improved BCIs, more trials

2023

Human trial by the end of 2023

The key people

Neuralink was co-founded by Elon Musk, Max Hodak, Tim Hanson, Ben Rapoport, Philip Sabes, and Vanessa Tolosa. They're pioneering breakthroughs in brain-machine interfaces, revolutionizing neuroscience and technology.

Valuation Comparables

Neurotechnology. EV/EBITDA (2021-2023)

The Investment Structure

Swiss SSPA Tracker-Certificate (Code 1300)

The average ticket size in private markets is usually between USD 1-5M. Moonshot uses structured products to split the investment size into smaller pieces, making them accessible to individual investors. Our tracker certificate follows the price movement of the assets and allows investors to gain investment exposure.

Learn more

Investor
Swiss Bank
HFWM AG
Issuer Collecting Service

HFWM AG collects payments from the issuer (e.g. interests, sales proceeds) and forwards funds to the investor.

HFWM AG
Investor Collecting Service

HFWM AG collects payments from the investors (via debt collection agreement) and forwards funds to the issues.

MISP AG

Issues tracker certificates, AMC, etc. and holds the securities (underlying) for the investor.

Securities Capital
Target Investment

Investment Process

Click on "Start investing"

Initiate the investment process by clicking on the "Start investing" button. Our process is completely digital and takes only a minute to complete. Make sure you have a digital passport copy ready for us.

Follow the process

During the process, you will be asked to confirm your personal details or define the investment party, e.g. if you're investing via a legal structure such as a company or SPV. The investment amount can be fined during the process.

Receive payment details

Once you have completed the investment process you will automatically receive payment details from our issuer or debt collector. Please make sure you use the payment reason we have defined in the email.

Pay & receive confirmation

As soon as your investment has been registered we will send you the investment confirmation via e-mail as well as physical mail and enter your investment to our securities registry.

Track investment

After your first investment is placed you will be able to follow it on your personalised investor dashboard.

What if you require unexpected liquidity?

Potential for liquidity

Moonshot acts as a “match-maker” via the in-house “Bulletin Board” should an investor require early liquidity.

The auto-adjusted return will be added to your securities (shares/bonds/certificates) as a default base-price finding in our investor network of over 10,000 active investors.

Important notice: Liquidity is not provided or guaranteed by Moonshot. Secondary offerings are only supported once Moonshot's primary offering has been closed and the minimum holding period has passed.


Performance

New valuations are published every quarter, semester, or year (as applicable). If available, Moonshot reviews and analyzes financials for its members.


Liquidity

We can quickly find a new buyer for your shares, should you require unexpected liquidity. Moonshot acts as a "match-maker" via the in-house "Bulletin Board”.


Insights

Know what’s going on before everyone else does. We keep you posted, as much as you like.

Questions?

Rely on our experienced team, which has decades of experience in private banking and has worked for some of the largest financial institutions in the world.

We are happy to help you find a suitable investment for you.

Details  Join WaitlistWaitlist  Book CallCall  Join NowApply  Share 
Share Moonshot and earn 2% reward

Invite your network to discover our exclusive private market investments, such as Synhelion or SpaceX, and earn lucrative rewards. If you share Moonshot as a logged-in user, you automatically make 2% (and up to 5% with our ambassador program) on your referral's first investment.

Copy sharing link Copy sharing text Share via WhatsApp Share via Email